Systems analysis of human brain gene expression: Mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease

BMC Medical Genomics

Volumn 6, Issue 1, 2013, Pages

  Levine, Andrew J ^a   Miller, Jeremy A ^a   Shapshak, Paul ^b   Gelman, Benjamin ^c   Singer, Elyse J ^a   Hinkin, Charles H ^a,d   Commins, Deborah ^e   Morgello, Susan ^f   Grant, Igor ^g   Horvath, Steve ^a,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CNS penetration effectiveness; Coexpression module; HIV encephalitis; HIV associated dementia; HIV associated neurocognitive disorder; National neuroAIDS tissue consortium; Weighted gene coexpression network analysis; WGCNA

Indexed keywords

ANTIRETROVIRUS AGENT; TRANSCRIPTOME;

ALZHEIMER DISEASE; ARTICLE; BRAIN MITOCHONDRION; BRAIN REGION; CELL FUNCTION; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; DRUG EFFICACY; EPIGENETICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC DAMAGE; GLIOSIS; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROPATHOLOGY; OLIGODENDROGLIA; PRIORITY JOURNAL; SERODIAGNOSIS; SYSTEMS BIOLOGY; TRANSCRIPTOMICS; VIRUS ENCEPHALITIS;

ALZHEIMER DISEASE; BRAIN; CEREBRAL CORTEX; CLUSTER ANALYSIS; DOWN-REGULATION; ENCEPHALITIS; GANGLIA; GENE REGULATORY NETWORKS; HIV INFECTIONS; HIV-1; HUMANS; TRANSCRIPTOME; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84876256285     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-4     Document Type: Article

References (91)

1. Updated research nosology for HIV-associated neurocognitive disorders. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Neurology 2007 69 18 1789 1799 10.1212/01.WNL.0000287431.88658.8b 17914061
2. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, Masliah E, Grant I, J Neurovirol 2007 13 1 23 28 10.1080/13550280601089175 17454445
3. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis R, Cherner M, Gelman B, J Neurovirol 2009 15 5-6 360 370 20175693
4. Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS, J Neuroimmunol 2004 157 1-2 163 175 15579294
5. Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration. Salaria S, Badkoobehi H, Rockenstein E, Crews L, Chana G, Masliah E, Everall IP, J Neurovirol 2007 13 6 496 503 10.1080/13550280701558616 18097881
6. Methamphetamine stimulates interferon inducible genes in HIV infected brain. Everall I, Salaria S, Roberts E, Corbeil J, Sasik R, Fox H, Grant I, Masliah E, J Neuroimmunol 2005 170 1-2 158 171 16249037
7. Translating the brain transcriptome in NeuroAIDS: from Non-human primates to humans. Winkler JM, Chaudhuri AD, Fox HS, J Neuroimmune Pharmacol 2012
8. Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, Taffe MA, Fox HS, Am J Pathol 2003 162 6 2041 2057 10.1016/S0002-9440(10)64336-2 12759259
9. An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction. Gersten M, Alirezaei M, Marcondes MC, Flynn C, Ravasi T, Ideker T, Fox HS, J Neurosci 2009 29 40 12467 12476 10.1523/JNEUROSCI.3180-09.2009 19812322
10. Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. Borjabad A, Brooks AI, Volsky DJ, J Neuroimmune Pharmacol 2010 5 1 44 62 10.1007/s11481-009-9167-1 19697136
11. The national NeuroAIDS tissue consortium brain gene array: Two types of HIV-associated neurocognitive impairment. Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical RS, Starkey JM, Masliah E, Commins DL, Brandt D, Grant I, Singer EJ, Levine AJ, Miller J, Luxon BA, Morgello S, PLoS One In Press
12. HIV-1 neuropathology. Gelman BM DJ, Neurology of AIDS Oxford University Press, Gendelman HE, Fox SH, Lipton SA, Everall IP, Grant I, Swindells S, Third 2012 518 535
13. WGCNA: an R package for weighted correlation network analysis. Langfelder P, Horvath S, BMC Bioinforma 2008 9 559 10.1186/1471-2105-9-559
14. Systems biology analysis of Sjogren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. Hu S, Zhou M, Jiang J, Wang J, Elashoff D, Gorr S, Michie SA, Spijkervet FK, Bootsma H, Kallenberg CG, Arthritis Rheum 2009 60 1 81 92 10.1002/art.24150 19116902
15. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Proc Natl Acad Sci U S A 2006 103 46 17402 17407 10.1073/pnas.0608396103 17090670
16. Functional organization of the transcriptome in human brain. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH, Nat Neurosci 2008 11 11 1271 1282 10.1038/nn.2207 18849986
17. Is my network module preserved and reproducible? Langfelder P, Luo R, Oldham MC, Horvath S, PLoS Comput Biol 2011 7 1 1001057 10.1371/journal.pcbi. 1001057 21283776
18. Divergence of human and mouse brain transcriptome highlights alzheimer disease pathways. Miller JA, Horvath S, Geschwind DH, Proc Natl Acad Sci U S A 2010 107 28 12698 12703 10.1073/pnas.0914257107 20616000
19. Molecular microcircuitry underlies functional specification in a basal ganglia circuit dedicated to vocal learning. Hilliard AT, Miller JE, Fraley ER, Horvath S, White SA, Neuron 2012 73 3 537 552 10.1016/j.neuron.2012.01.005 22325205
20. Weighted gene coexpression network analysis strategies applied to mouse weight. Fuller TF, Ghazalpour A, Aten JE, Drake TA, Lusis AJ, Horvath S, Mamm Genome 2007 18 6-7 463 472 17668265
21. Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. Mason MJ, Fan G, Plath K, Zhou Q, Horvath S, BMC Genomics 2009 10 327 10.1186/1471-2164-10-327 19619308
22. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia. Plaisier CL, Horvath S, Huertas-Vazquez A, Cruz-Bautista I, Herrera MF, Tusie-Luna T, Aguilar-Salinas C, Pajukanta P, PLoS Genet 2009 5 9 1000642 10.1371/journal.pgen.1000642 19750004
23. Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. Presson AP, Sobel EM, Papp JC, Suarez CJ, Whistler T, Rajeevan MS, Vernon SD, Horvath S, BMC Syst Biol 2008 2 95 10.1186/1752-0509-2-95 18986552
24. Weighted gene co-expression network analysis of the peripheral blood from amyotrophic lateral sclerosis patients. Saris CG, Horvath S, van Vught PW, van Es MA, Blauw HM, Fuller TF, Langfelder P, DeYoung J, Wokke JH, Veldink JH, BMC Genomics 2009 10 405 10.1186/1471-2164-10-405 19712483
25. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW, Proc Natl Acad Sci U S A 2004 101 7 2173 2178 10.1073/pnas.0308512100 14769913
26. Alzheimer's disease and HIV associated dementia related genes: I. location and function. Shapshak P, Rodriguez HE, Kayathri R, Levine A, Chiappelli F, Minagar A, Bioinformation 2008 2 8 348 357 10.6026/97320630002348 18685724
27. HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review. Minagar A, Shapshak P, Duran EM, Kablinger AS, Alexander JS, Kelley RE, Seth R, Kazic T, J Neurol Sci 2004 224 1-2 3 17 15450765
28. A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. Miller JA, Oldham MC, Geschwind DH, J Neurosci 2008 28 6 1410 1420 10.1523/JNEUROSCI.4098-07.2008 18256261
29. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Arch Neurol 2008 65 1 65 70 10.1001/archneurol.2007.31 18195140
30. The national NeuroAIDS tissue consortium: a new paradigm in brain banking with an emphasis on infectious disease. Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer EJ, Neuropathol Appl Neurobiol 2001 27 4 326 335 10.1046/j.0305-1846.2001.00334.x 11532163
31. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, J Acquir Immune Defic Syndr 2007 45 2 174 182 10.1097/QAI.0b013e318042e1ee 17356465
32. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, McCutchan JA, Heaton RK, Ellis RJ, Neurology 2009 73 5 342 348 10.1212/WNL.0b013e3181ab2b3b 19474412
33. Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Marra CM, Lockhart D, Zunt JR, Perrin M, Coombs RW, Collier AC, Neurology 2003 60 8 1388 1390 10.1212/01.WNL.0000058768.73358.1A 12707454
34. Comparative analysis of microarray normalization procedures: effects on reverse engineering gene networks. Lim WK, Wang K, Lefebvre C, Califano A, Bioinformatics 2007 23 13 282 288 10.1093/bioinformatics/btm201 17646307
35. Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Oldham MC, Horvath S, Geschwind DH, Proc Natl Acad Sci U S A 2006 103 47 17973 17978 10.1073/pnas.0605938103 17101986
36. Strategies for aggregating gene expression data: the collapseRows R function. Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, Salomon DR, Horvath S, BMC Bioinformatics 2011 12 322 10.1186/1471-2105-12-322 21816037
37. Identifying biological themes within lists of genes with EASE. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA, Genome Biol 2003 4 10 70 10.1186/gb-2003-4-10-r70 14519205
38. GNCPro: navigate human genes and relationships through net-walking. Liu GG, Fong E, Zeng X, Adv Exp Med Biol 2010 680 253 259 10.1007/978-1-4419-5913-3- 29 20865508
39. Coexpression analysis of human genes across many microarray data sets. Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P, Genome Res 2004 14 6 1085 1094 10.1101/gr.1910904 15173114
40. Promoter features related to tissue specificity as measured by Shannon entropy. Schug J, Schuller WP, Kappen C, Salbaum JM, Bucan M, Stoeckert CJ Jr, Genome Biol 2005 6 4 33 10.1186/gb-2005-6-4-r33 15833120
41. A general framework for weighted gene co-expression network analysis. Zhang B, Horvath S, Stat Appl Genet Mol Biol 2005 4 rticle17 16646834
42. Eigengene networks for studying the relationships between co-expression modules. Langfelder P, Horvath S, BMC Syst Biol 2007 1 54 10.1186/1752-0509-1-54 18031580
43. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH, Nature 2011 474 7351 380 384 10.1038/nature10110 21614001
44. Integrating genetic and network analysis to characterize genes related to mouse weight. Ghazalpour A, Doss S, Zhang B, Wang S, Plaisier C, Castellanos R, Brozell A, Schadt EE, Drake TA, Lusis AJ, PLoS Genet 2006 2 8 130 10.1371/journal.pgen.0020130 16934000
45. Hierarchical organization of modularity in metabolic networks. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL, Science 2002 297 5586 1551 1555 10.1126/science.1073374 12202830
46. Gene network interconnectedness and the generalized topological overlap measure. Yip AM, Horvath S, BMC Bioinforma 2007 8 22 10.1186/1471-2105-8-22
47. Defining clusters from a hierarchical cluster tree: the dynamic tree Cut package for R. Langfelder P, Zhang B, Horvath S, Bioinformatics 2008 24 5 719 720 10.1093/bioinformatics/btm563 18024473
48. Geometric interpretation of gene coexpression network analysis. Horvath S, Dong J, PLoS Comput Biol 2008 4 8 1000117 10.1371/journal.pcbi.1000117 18704157
49. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Folstein MF, Folstein SE, McHugh PR, J Psychiatr Res 1975 12 3 189 198 10.1016/0022-3956(75)90026-6 1202204
50. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Winston A, Duncombe C, Li PC, Gill JM, Kerr SJ, Puls R, Petoumenos K, Taylor-Robinson SD, Emery S, Cooper DA, Clin Infect Dis 2010 50 6 920 929 10.1086/650743 20146627
51. Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration. Zhou L, Sokolskaja E, Jolly C, James W, Cowley SA, Fassati A, PLoS Pathog 2011 7 8 1002194 10.1371/journal.ppat.1002194 21901095
52. Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus. De Iaco A, Luban J, Retrovirology 2011 8 98 10.1186/1742-4690-8-98 22145813
53. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, J Neurosci 2008 28 1 264 278 10.1523/JNEUROSCI.4178-07. 2008 18171944
54. Weighted gene co-expression network analysis identifies biomarkers in glycerol kinase deficient mice. MacLennan NK, Dong J, Aten JE, Horvath S, Rahib L, Ornelas L, Dipple KM, McCabe ER, Mol Genet Metab 2009 98 1-2 203 214 19546021
55. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, J Neurovirol 2011 17 1 3 16 10.1007/s13365-010-0006-1 21174240
56. Expression of Id proteins increases in astrocytes in the hippocampus of epileptic rats. Aronica E, Vandeputte DA, van Vliet EA, da Silva FH L, Troost D, Gorter JA, Neuroreport 2001 12 11 2461 2465 10.1097/00001756-200108080-00035 11496130
57. Tumor necrosis factor-alpha regulation of the Id gene family in astrocytes and microglia during CNS inflammatory injury. Tzeng SF, Kahn M, Liva S, De Vellis J, Glia 1999 26 2 139 152 10.1002/(SICI)1098-1136(199904)26: 2<139::AID-GLIA5>3.0.CO;2-1 10384879
58. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A, Genes Dev 1995 9 1 15 30 10.1101/gad.9.1.15 7828849
59. An experimental model system for HIV-1-induced brain injury. Gendelman HE, Genis P, Jett M, Zhai QH, Nottet HS, Adv Neuroimmunol 1994 4 3 189 193 10.1016/S0960-5428(06)80256-1 7874386
60. A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations. Pulliam L, Rempel H, Sun B, Abadjian L, Calosing C, Meyerhoff DJ, AIDS 2011 25 14 1721 1726 10.1097/QAD.0b013e328349f022 21750421
61. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, Macrae AD, Torres GE, Kim KM, Lefkowitz RJ, Caron MG, Neuron 2003 38 2 291 303 10.1016/S0896-6273(03)00192-2 12718862
62. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M, J Neurovirol 2011 17 1 26 40 10.1007/s13365-010-0003-4 21165787
63. HIV dementia: the role of the basal ganglia and dopaminergic systems. Berger JR, Arendt G, J Psychopharmacol 2000 14 3 214 221 10.1177/ 026988110001400304 11106299
64. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS, Neuroimage 2008 42 2 869 878 10.1016/j.neuroimage.2008.05.011 18579413
65. Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients. di Rocco A, Bottiglieri T, Dorfman D, Werner P, Morrison C, Simpson D, Clin Neuropharmacol 2000 23 4 190 194 10.1097/00002826-200007000-00004 11020122
66. Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. Gelman BB, Spencer JA, Holzer CE 3rd, Soukup VM, J Neuroimmune Pharmacol 2006 1 4 410 420 10.1007/s11481-006-9030-6 18040813
67. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. Kumar AM, Fernandez JB, Singer EJ, Commins D, Waldrop-Valverde D, Ownby RL, Kumar M, J Neurovirol 2009 15 3 257 274 10.1080/13550280902973952 19499455
68. Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH Jr, Soukup VM, J Neuroimmune Pharmacol 2012 7 3 686 700 10.1007/s11481-012-9345-4 22391864
69. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO, Proc Natl Acad Sci U S A 1998 95 6 3117 3121 10.1073/pnas.95.6.3117 9501225
70. HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS. Eugenin EA, Dyer G, Calderon TM, Berman JW, Glia 2005 49 4 501 510 10.1002/glia.20137 15578658
71. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Proc Natl Acad Sci U S A 2002 99 21 13795 13800 10.1073/pnas.202357499 12374865
72. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. Weiss JM, Nath A, Major EO, Berman JW, J Immunol 1999 163 5 2953 2959 10453044
73. Persistent hijacking of brain proteasomes in HIV-associated dementia. Nguyen TP, Soukup VM, Gelman BB, Am J Pathol 2010 176 2 893 902 10.2353/ajpath.2010.090390 20035054
74. Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes. Gelman BB, Nguyen TP, J Neuroimmune Pharmacol 2010 5 1 92 102 10.1007/s11481-009-9168-0 19693676
75. Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M, Clayton D, Brown M, Samani N, Dominiczak A, Hum Mol Genet 2005 14 13 1805 1814 10.1093/hmg/ddi187 15888480
76. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases. Ray M, Ruan J, Zhang W, Genome Biol 2008 9 10 148 10.1186/gb-2008-9-10-r148 18842138
77. RGM and its receptor neogenin regulate neuronal survival. Matsunaga E, Tauszig-Delamasure S, Monnier PP, Mueller BK, Strittmatter SM, Mehlen P, Chedotal A, Nat Cell Biol 2004 6 8 749 755 10.1038/ncb1157 15258591
78. Up-regulation of MAP2e-expressing oligodendrocytes in the white matter of patients with HIV-1 encephalitis. Cosenza MA, Zhao ML, Shankar SL, Shafit-Zagardo B, Lee SC, Neuropathol Appl Neurobiol 2002 28 6 480 488 10.1046/j.1365-2990.2002.00420.x 12445164
79. Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study. Lackner P, Kuenz B, Reindl M, Morandell M, Berger T, Schmutzhard E, Eggers C, J Neuroinflammation 2010 7 79 10.1186/1742-2094-7-79 21083890
80. The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes. Jayadev S, Yun B, Nguyen H, Yokoo H, Morrison RS, Garden GA, J Neuroimmune Pharmacol 2007 2 4 359 370 10.1007/s11481-007-9095-x 18040854
81. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Bartzokis G, Neurobiol Aging 2011 32 8 1341 1371 10.1016/j. neurobiolaging.2009.08.007 19775776
82. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical disconnection in aging and Alzheimer's disease. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL, Neurobiol Aging 2004 25 7 843 851 10.1016/j.neurobiolaging.2003.09.005 15212838
83. Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. Borjabad A, Morgello S, Chao W, Kim SY, Brooks AI, Murray J, Potash MJ, Volsky DJ, PLoS Pathog 2011 7 9 1002213 10.1371/journal.ppat.1002213 21909266
84. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, AIDS 2009 23 11 1359 1366 10.1097/QAD.0b013e32832c4152 19424052
85. Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease. Garvey L, Winston A, Walsh J, Post F, Porter K, Gazzard B, Fisher M, Leen C, Pillay D, Hill T, Neurology 2011 76 8 693 700 10.1212/WNL.0b013e31820d8b0b 21339496
86. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease. Serrano-Pozo A, Mielke ML, Gomez-Isla T, Betensky RA, Growdon JH, Frosch MP, Hyman BT, Am J Pathol 2011 179 3 1373 1384 10.1016/j.ajpath.2011.05.047 21777559
87. Cerebral amyloid angiopathy and astrocytic gliosis in Alzheimer's disease. Mandybur TI, Acta Neuropathol 1989 78 3 329 331 10.1007/BF00687764 2763806
88. Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis. Xing HQ, Hayakawa H, Gelpi E, Kubota R, Budka H, Izumo S, J Neuropathol Exp Neurol 2009 68 2 199 209 10.1097/NEN.0b013e31819715df 19151621
89. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Gelman BB, Ann Neurol 1993 34 1 65 70 10.1002/ana.410340112 8517682
90. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, Ernst T, Singer E, Richards T, Jarvik GJ, J Neuropsychiatry Clin Neurosci 2007 19 3 283 292 10.1176/appi.neuropsych.19.3.283 17827413
91. Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer's Disease, and Multiple Sclerosis. Borjabad A, Volsky DJ, J Neuroimmune Pharmacol 2012 7 4 914 926 10.1007/s11481-012-9409-5 23065460